To exclude the mesenchymal invasion, we assayed the invasive ability of lactate-exposed PCa cells by using the Rho and matrix metalloproteinases (MMPs) inhibitors, CT04 and Marimastat, respectively. The gene discussed is RHO; the disease is posterior cortical atrophy.